Accelr8 and Schott Nexterion in Supply Pact, and Intend Transfer of Microarray Technology

NEW YORK, Oct. 15 (GenomeWeb News) - Accelr8 Technology of Denver and Schott Nexterion, the Mainz, Germany-based wholly-owned subsidiary of Schott, the European glass manufacturer, today announced a supply agreement and a letter of intent for an exclusive technology transfer license for Accelr8's OptiChem surface chemistry products.

Financial details of the agreement were not provided.

Under the supply agreement, Schott will resell Accelr8's OptArray microarray slides under its brand and Accelr8 will continue to manufacture the microarraying products in its Denver facility. Accelr8 will be Schott Nexterion's sole supplier of permeable hydrogel microarraying slides during the term of the supply agreement and will provide sales training and technical support to Schott's customers.

Under the intended technology transfer license, Schott will become the exclusive outsource manufacturer for OptArray products starting in the third quarter of 2004, Accelr8 said in a statement. Schott will manufacture the OptArray slides and have exclusive marketing rights to those products, Accelr8 said. The two companies will cooperatively market the products, and Accelr8 will provide technology transfer consulting services to facilitate the transition.